Compare uniQure N.V. Ordinary Shares (QURE) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Standard Lithium Ltd — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while Standard Lithium Ltd trades at $1.41 (market cap $354.24M). The key difference: uniQure N.V. Ordinary Shares is far larger — about 4.2× Standard Lithium Ltd's market cap, and uniQure N.V. Ordinary Shares is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Standard Lithium Ltd for 24 Days on average.
| QURE | SLI | |
|---|---|---|
Market Cap | $1.48B | $354.24M |
Volume | 2,488,780 | 1,656,773 |
Sector | Health | Basic Materials |
52-Week High | $70.59 | $5.65 |
52-Week Low | $9.03 | $1.38 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $728.62M | $217.16M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Standard Lithium (SLI) trades at $1.43, down 4.03% today, with a bearish technical signal despite bullish oscillators. The company shows negative profitability with ROE at -15.55% and no current revenue, but has made significant progress on its Arkansas lithium project with recent offtake agreements and government support. Analyst consensus remains strongly bullish with 100% buy ratings and a $3.83 price target, representing 168% upside potential from current levels.
The investment case hinges on successful execution of the South West Arkansas project, which could begin production in 2029. Key risks include negative cash flow from operations, high capital requirements, and project timeline delays. The stock offers speculative upside if the company can transition from development to production phase successfully.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
